AptinyxLogo_FullColor_RGB.jpg
Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference
August 06, 2019 08:33 ET | Aptinyx Inc.
EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
AptinyxLogo_FullColor_RGB.jpg
Aptinyx to Report First Quarter 2019 Financial Results on Tuesday, May 14, 2019
May 06, 2019 07:27 ET | Aptinyx Inc.
EVANSTON, Ill., May 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
AptinyxLogo_FullColor_RGB.jpg
Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers
April 30, 2019 07:27 ET | Aptinyx Inc.
Favorable overall safety, tolerability, and pharmacokinetic profile—no serious adverse events reported across wide dose range Achieved ample CNS exposure consistent with exposure observed at...
Servier backs an American startup at LabCentral in the field of mitochondrial health for neurodegenerative and rare diseases
November 14, 2018 02:00 ET | LabCentral
PARIS, France and CAMBRIDGE, Mass. USA, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Servier, an independent international pharmaceutical laboratory, and LabCentral, a well-known launchpad for innovative life...
cfn_tweakedspacing.jpg
IGC Partners to Advance Cannabinoid Based Parkinson's Disease Therapy Research -- CFN Media
March 14, 2018 09:00 ET | CFN Media
Seattle, WA , March 14, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
MRI Interventions' ClearPoint® Neuro Navigation Technology Highlighted in Voyager Therapeutics, Inc. Interim Parkinson’s Disease Gene Therapy Study Results
June 23, 2016 16:05 ET | MRI Interventions, Inc.
IRVINE, Calif., June 23, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next...
ClearPoint-13169-Final-Logo-CMYK jpg.jpg
MRI Interventions’ ClearPoint® Neuro Navigation System Utilized for the First Time at Inova Fairfax Hospital
May 31, 2016 16:30 ET | ClearPoint Neuro, Inc.
IRVINE, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative neuro navigation platforms for...